Glipizide Tablets

Duramed Pharmaceuticals

Approval Status
Approved September 1997

Treatment for

Diabetes / Endocrinology

The U.S. Food and Drug Administration has authorized Duramed Pharmaceuticals, Inc. to market Glipizide tablets, a treatment for diabetes, in the 5 mg and 10 mg strengths. The FDA granted Duramed's Glipizide tablets a therapeutic equivalency rating of AB, designating Duramed's Glipizide tablets as completely interchangeable with Glucotrol (R) tablets for all new and refill prescriptions.

Glipizide Tablets Drug Information

The Glipizide Tablets drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top